Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre- and Post-operative Compared to Post-operative Only Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery
NCT06159777Phase 4Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jun 2024
- Primary completion
- Mar 2026
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
A Phase 4 trial of polyethylene glycol 3350 in constipation, sponsored by University Hospitals Cleveland Medical Center. Started Jun 2024; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
constipation
Beyond the preview
Go deeper on NCT06159777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06159777.